Baird upgrades Vertex Pharmaceuticals, shares attractive ahead of readouts

While recent pullback in Seattle Genetics, Inc’s (NASDAQ: SGEN) shares presents an attractive entry point, there are several pipeline catalysts ahead, according to O.....»»

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Shares of Vertex Pharmaceuticals Inc. were down 4.3% in trading on Tuesday, the day after the company discussed its deal-making strategy with analysts during its fourth-quarter earnings call. The company said it is considering buying companies wi.....»»

Vertex Pharmaceuticals (NASDAQ: VRTX) shares are trading higher after Argus Research maintained a Buy rating on the stock and raised its price.....»»

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Friday's top analyst upgrades, downgrades and initiations included Amazon.com, Amgen, Coca-Cola, Danaher, Electronic Arts, IBM, Proofpoint, Sprint, UPS, Uber, Vertex Pharmaceuticals and Visa......»»

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Vertex Pharmaceuticals Inc. shares rose in the extended session Thursday after the biotech drug maker's results and forecast topped Wall Street estimates. Vertex shares rose 2.9% after .....»»

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

There are potential upside catalysts for iRobot Corporation’s (NASDAQ: IRBT) stock and few negative catalysts that could push shares below the $45-$55 range, according to Raymond James. Latest Ratings for IRBT Dat.....»»

Downgrades Cantor Fitzgerald downgraded Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) from Overweight to Neutral. Spectrum Pharmaceuticals shares closed at $8.75 on Tuesday. 0.....»»

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Zynerba Pharmaceuticals Inc (NASDAQ: ZYNE) shares ended Monday's session nearly 15% higher after Canaccord Genuity said the stock's mid-September sell-off was unjustified.  Latest Ratings for ZYNE .....»»

It’s been a good year for Thomson Reuters Corp (NYSE: TRI), but one Wall Street analyst said Monday there’s even more upside ahead for the stock. Latest Ratin.....»»

After initially popping as high as $39 per share following its summer IPO, Chewy Inc (NYSE: CHWY) shares are down 14% in the past three months as excitement ove.....»»

Square Inc. shares have been largely flat in recent months, but a pair of analysts now see better times ahead for the fintech stock. MoffettNath.....»»

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Canopy Growth Corp. shares rose 1.6% in premarket trade Monday, after Seaport Global upgraded the stock to buy from neutral and said it now looks attractive after a steep selloff. Canopy s.....»»

Shares of thinly traded small-cap biotech Deciphera Pharmaceuticals Inc (NASDAQ: DCPH) are skyrocketing Tuesday morning following a couple of clinical readouts from the company. read more.....»»